Anika Therapeutics Inc — Quarterly Cash Flow (NASDAQ:ANIK) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Total assets 231.41 M202.74 M190.6 M187.68 M189.44 M Total liabilities 51.54 M48.09 M42.21 M40.01 M42.63 M Total equity 179.86 M153.99 M148.4 M147.67 M146.81 M Total liabilities & shareholders' equities 231.41 M202.74 M190.6 M187.68 M189.44 M Total debt ————— Net debt —————

Notícias

Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

Anika Q4 2025: l’impennata commerciale compensa il calo OEM

Anika Q4 2025 slides: commercial surge offsets OEM decline

Anika earnings beat by $0.45, revenue topped estimates

Lumicell appoints Cheryl Blanchard to board of directors

Anika Therapeutics names Stephen Griffin as new CEO

Slide di Anika del Q3 2025: La crescita commerciale compensa il calo OEM

Anika Q3 2025 slides: Commercial growth offsets OEM decline

Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates

Anika earnings beat by $0.22, revenue was in line with estimates

Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains?

Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?